|  | RLS + ICBs | RLSnonICBs | p-value |
---|---|---|---|---|
Total number | Â | n = 10 | n = 130 | Â |
Female gender | Â | n = 10 (100%) | n = 88 (67.6%) | 0.04 |
Mean age of RLS onset in years (SD) | Â | 46.6 (10.1) | 57 (15.9) | 0.04 |
Medication | Dopaminergic | n = 10 (100%) | n = 122 (93.8%) | 0.4 |
 | Other | n = 0 (0%) | n = 8 (6.2%) |  |
Da type | Ropinirole | n = 3 (37.5%) | n = 29 (29.8%) | 0.6 |
 | Pramipexole | n = 3 (37.5%) | n = 43 (44.3%) | 0.5 |
 | Other | n = 2 (25%) | n = 25 (25.7%) | 0.3 |
Mean DA dose as LEDD mg/d *(SD) | Â | 63.7 (52.7) | 26.7 (26.4) | 0.001 |
FHx alcohol use disorder | Â | n = 3 (30%) | n = 12 (9.2%) | 0.09 |
FHx gambling disorder | Â | n = 2 (20%) | n = 2 (2%) | 0.02 |
Hx experimental drug use | Â | n = 5 (50%) | n = 10 (7.9%) | 0.002 |
Cigarettes smoked daily | 0 | n = 5 (50%) | n = 81 (62.3%) | 0.19 |
 | 1-10 | n = 0 (0%) | n = 10 (13%) |  |
 | 11-20 | n = 3 (30%) | n = 13 (10%) |  |
 | 21-29 | n = 0 (0%) | n = 6 (6%) |  |
 | > 30 | n = 2 (20%) | n = 10 (13%) |  |
Alcohol daily glasses | 0 | n = 8 (80%) | n = 70/118 (59.3%) | 0.18 |
 | 1-7 | n = 2 (20%) | n = 41/118 (34.8%) |  |
 | 8-14 | n = 0 (0%) | n = 5/118 (4.2%) |  |
 | 15-21 | n = 0 (0%) | n = 2/118 (1.7%) |  |
 | > 22 | n = 0 (0%) | n = 0 (0%) |  |
Mean novelty seeking score (SD) | Â | 20.8 (5.3) | 18 (5.5) | 0.13 |